Impedimed Limited ( (AU:IPD) ) has provided an announcement.
ImpediMed Limited has announced a change in the director’s interest, with Mr. Andrew Grant acquiring an additional 197,647 ordinary shares, bringing his total to 2,506,230 shares. This acquisition was made through the issuance of shares in lieu of 30% of his director fees for the quarter ended March 31, 2025, reflecting a strategic move to align director compensation with company performance, potentially impacting stakeholder perceptions positively.
More about Impedimed Limited
ImpediMed Limited operates in the healthcare industry, specializing in medical technology. The company is known for its products that focus on non-invasive medical devices for the assessment of body composition and fluid status, which are crucial in managing conditions such as lymphedema and heart failure.
YTD Price Performance: -44.44%
Average Trading Volume: 72,592
Technical Sentiment Signal: Buy
Current Market Cap: $44.18M
For detailed information about IPD stock, go to TipRanks’ Stock Analysis page.